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Abstract
 
Apoptotic cells are rapidly phagocytosed by professional phagocytes, such as macrophages and
dendritic cells. This process prevents the release of potentially noxious or immunogenic intra-
cellular materials from dying cells, and is thought to play a critical role for the maintenance of
normal functions in surrounding tissues. Milk fat globule-EGF-factor 8 (MFG-E8), secreted by
activated macrophages and immature dendritic cells, links apoptotic cells and phagocytes, and
promotes phagocytosis of apoptotic cells. Here, we report that an MFG-E8 mutant, designated
as D89E, carrying a point mutation in an RGD motif, inhibited not only the phagocytosis of
apoptotic cells by a wide variety of phagocytes, but also inhibited the enhanced production of
IL-10 by thioglycollate-elicited peritoneal macrophages phagocytosing apoptotic cells. When
intravenously injected into mice, the D89E protein induced the production of autoantibodies
including antiphospholipids antibodies and antinuclear antibodies. The production of autoanti-
bodies was enhanced by the coinjection of syngeneic apoptotic thymocytes. After the induc-
tion of autoantibody production by D89E, the treated mice showed a long-term elevation of
the titer for autoantibodies, and developed IgG deposition in the glomeruli. These results indi-
cated that the impairment of apoptotic cell phagocytosis led to autoantibody production.
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Introduction
 
Unnecessary or potentially harmful cells are eliminated by
programmed cell death or apoptosis (1, 2). When cells re-
ceive apoptotic stimuli, endogenous caspases—a family of
cysteine proteases—are autonomously activated. These ac-
tive caspases cleave their target molecules, including cyto-
skeletal and structure proteins, and cell cycle regulators (3,
4). This, proteolysis makes the targets either active or inac-
tive, which lead to morphological and biochemical changes
that characterize apoptotic cell death. Apoptotic cells are
rapidly engulfed by phagocytes, such as macrophages and
dendritic cells, or neighboring cells. The clearance of dead
cells prevents the release of potentially toxic or immuno-
genic intracellular materials from dead cell corpses. There-
fore, even tissues with high cell turnover rates are free from
inflammation. Soon after engulfment, the components of
apoptotic cell corpses are degraded in the lysosome of
phagocytes. Chromosomal DNA degradation of apoptotic
cells is performed not only cell autonomously by the action
of CAD, but also by the lysosomal DNase of phagocytes
(5). DNase II–deficient mice showed dead cell–derived
DNA accumulation in thymic macrophages and impair-
ment of thymic development in association with the in-
duction of the interferon genes (6), indicating that phago-
cytosis of apoptotic cells and subsequent degradation of
apoptotic cell materials are essential for organ development
and homeostasis.
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To engulf apoptotic cells, phagocytes must recognize
ligands found on apoptotic cells that are absent on living
cells (7–9). In mammals, the recognition and engulfment of
apoptotic cells by phagocytes is an intricate process, and a
number of molecules on phagocytes were found to be in-
volved in this phenomenon (10–12). According to the
two-step model (13), apoptotic cells are first tethered to
phagocytes through the interaction between putative
ligands and receptors, and then are engulfed by phagocytes
through recognition of phosphatidylserine (PS) exposed on
apoptotic cells. Some receptor molecules, including phos-
phatidylserine receptor (14), LDL receptor (15), and scaven-
ger receptors (16), directly recognize PS on apoptotic cells.
In addition, soluble proteins that bind to PS on apoptotic
cells for phagocytosis were also reported (17). However,
how these receptors are involved in the recognition and en-
gulfment of apoptotic cells has not been fully understood.
We have previously shown that milk fat globule-EGF-
factor 8 (MFG-E8) is involved in apoptotic cell phagocytosis
by phagocytes (18). MFG-E8 was originally identified as a
component of milk fat globules (19–21), and is also pro-
duced and secreted by activated macrophages. MFG-E8 spe-
cifically binds to PS exposed on apoptotic cells via COOH-
terminal factor VIII homologous domains. When MFG-E8
is engaged by apoptotic cells, it binds to 
 
 
 
v
 
 
 
3
 
 integrin ex-
pressed in phagocytes via a NH
 
2
 
-terminal EGF-like domain,
and promotes the phagocytosis of apoptotic cells.
In this paper, we show that an MFG-E8 mutant protein,
carrying a mutation in the RGD sequence, inhibited the
phagocytosis of apoptotic cells by a wide variety of phago-
cytes through the masking of PS on apoptotic cells. To re-
veal the consequence of failure for apoptotic cell engulf-
ment in vivo, D89E protein was intravenously injected
into mice. The mice developed sustained autoantibody
production and deposition of immunoglobulin in the glo-
meruli of the kidney. The production of autoantibodies
was enhanced by the coinjection of apoptotic cells. These
results suggested that apoptotic cell engulfment is required
for the maintenance of self-tolerance.
 
Materials and Methods
 
Preparation of Recombinant MFG-E8.
 
Recombinant MFG-
E8-L and its mutant proteins were prepared as described previ-
ously (18). In brief, the expression plasmid of wild-type MFG-
E8-L, D89E carrying RGE sequence instead of RGD in the
second EGF-like domain, or E1E2PT lacking the C1C2 domains
were introduced into human 293T cells by the calcium phos-
phate precipitation method. The culture medium was replaced
with DMEM/2% FCS 16 h after transfection, and the transfected
cells were cultured for another 48 h. The recombinant proteins
secreted into the medium were purified using anti–FLAG M2
affinity gel (Sigma-Aldrich), or anti–MFG-E8 antibody (clone
2422)–conjugated protein A–Sepharose 4FF beads (Amersham
Biosciences). To examine the purity of the proteins, they were
subjected to SDS-PAGE and Western blotting. For SDS-PAGE,
proteins were separated by electrophoresis on a 10/20% poly-
acrylamide gradient gel and stained with Coomassie brilliant blue.
For Western blotting, proteins were separated by electrophoresis,
transferred to PVDF membranes, and detected with anti-FLAG
antibody. We confirmed that the recombinant proteins alone did
not stimulate the production of inflammatory cytokines including
TNF
 
 
 
 and IL-1
 
 
 
 in macrophages.
 
In Vitro Phagocytosis Assay and Measurement of Cytokines Produc-
tion.
 
For the preparation of bone marrow–derived macrophages
(BMDMs), bone marrow cells were obtained by flushing the fe-
murs from 8–10-wk-old C57BL/6 mice. The cells were treated
with RBC lysis buffer (17 mM Tris-HCl, pH 7.5, 144 mM am-
monium chloride, and 0.5% FCS) for 1 min at room tempera-
ture. Next, the cells were suspended in 
 
 
 
MEM/10% FCS me-
dium, and were plated at a density of 10
 
6
 
 cells/ml in the presence
of recombinant mouse M-CSF (a gift from A. Kudo, Tokyo Insti-
tute of Technology, Kanagawa, Japan). Cells were harvested on
day 3, diluted 1:10 with the medium, and cultured for another
3 d at 37
 
 
 
C. On day 6, the cells were used for phagocytosis assay.
2.5 
 
 
 
 10
 
5
 
 BMDMs were seeded in a 48-well cell culture cluster
(Corning Inc.) and cultured overnight at 37
 
 
 
C. Cells were prein-
cubated with or without D89E (1, 2, and 4 
 
 
 
g/ml) or E1E2PT
protein (4 
 
 
 
g/ml) for 30 min. For the preparation of apoptotic
cells, thymocytes from 4 to 8–wk-old CAD-deficient mice (6)
were incubated with 10 
 
 
 
M dexamethasone at 37
 
 
 
C for 4 h.
2.5 
 
 
 
 10
 
6
 
 of apoptotic thymocytes were added to BMDM cul-
tures, and phagocytosis was allowed to proceed for 2 h. Cells not
being engulfed were removed by washing with PBS, and the
BMDMs were detached with 1 mM EDTA/PBS. Afterwards,
the cells were stained with PE-conjugated anti–mouse CD11b,
followed by TUNEL staining as described previously (18).
Resident peritoneal macrophages were suspended in DMEM/
10% FCS and 10
 
5 
 
cells were seeded in a 96-well cell culture clus-
ter. The cells were incubated 3 h at 37
 
 
 
C and used for the phago-
cytosis assay.
For cytokine assay, 10
 
5
 
 cells of thioglycollate-elicited perito-
neal macrophages from C57BL/6 were seeded in a 96-well cell
culture cluster. The macrophages were preincubated with or
without D89E or E1E2PT protein for 30 min. Then, 2 
 
 
 
 10
 
6
 
cells of apoptotic thymocytes induced by UV irradiation were
added to the macrophages for phagocytosis. After 2-h incubation,
the macrophages were washed twice, and were stimulated with
or without 1 
 
 
 
g/ml LPS for 20 h. For the measurement of
TGF-
 
 
 
, the culture medium was changed to AIM-V (Invitro-
gen) 1 h after stimulation with or without LPS, and the cells were
incubated for 20 h. Cytokine concentrations in the culture super-
natants were measured using ELISA kits for IL-10, TNF
 
 
 
 (BD
Biosciences), and TGF-
 
 
 
 (R&D Systems) according to manufac-
turer’s protocols.
 
Injection of Recombinant Proteins and Apoptotic Cells.
 
The puri-
fied recombinant proteins were diluted with PBS containing
2.5% normal mouse serum obtained from C57BL/6 mice, and
300 
 
 
 
l of the solution was intravenously injected into 8-wk-old
C57BL/6 female mice through the tail vein. In the case of apop-
totic thymocyte injection, thymi from 4 to 6–wk-old C57BL/6
mice were removed and squeezed between glass slides. Thy-
mocytes were then filtrated through a nylon mesh, and suspended
in serum-free RPMI 1640 medium. The cells were irradiated
with 40 J/m
 
2
 
 UV light to induce apoptosis and were cultured in
RPMI 1640 medium containing 1% normal mouse serum at
37
 
 
 
C for 20 h. Next, the cells were washed twice with PBS con-
taining 1 mg/ml of mouse serum albumin and suspended in PBS
containing 2.5% normal mouse serum. Recombinant MFG-E8
was added to apoptotic thymocytes 30 min before injection, and
the cells were intravenously injected into mice. Immunizations
were performed weekly for a total of four to six injections. 
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Detection of Autoantibodies
 
The serum levels of anticardiolipin
antibody and anti-PS antibody were detected by ELISA. 96-well
ELISA plates (Immulon 1B microtiter plate; ThermoLabsystems)
were coated with 10 
 
 
 
g/ml cardiolipin (CL) in methanol or 10
 
 
 
g/ml 
 
l
 
-
 
 
 
-phosphatidyl-
 
l
 
-serine, dioleoyl (Sigma-Aldrich) in
ethanol. After blocking with 10% FCS, mice sera diluted 50 times
with PBS were added and incubated for 1 h at room temperature.
The mouse antibodies bound to the plate were detected using
goat anti–mouse Ig conjugated to HRP (ICN Biomedicals) at a
dilution of 1:2,000. The peroxidase activity was detected using
 
o
 
-phenylenediamine in the peroxidase detection kit (Sumitomo)
as a substrate. The color reaction was read at 492 nm using a mi-
croplate reader (Titertek Instruments).
Antinuclear antibody (ANA) was detected by indirect immu-
nofluorescence and ELISA. For immunofluorescence, serum
samples were diluted 50 times with PBS, and were added on glass
slides coated with Hep-2 cells (MBL). The slides were incubated
at 37
 
 
 
C in a humid chamber for 30 min. The antibodies bound to
the slides were detected by Cy3-conjugated F(ab
 
 
 
)
 
2
 
 of goat anti–
mouse IgG (Jackson ImmunoResearch Laboratories) diluted 100
times with PBS/10% normal goat serum. Slides were observed by
fluorescence microscopy (model IX-70; Olympus).
ANAs were also detected by using an ANA detection kit
(MBL). Mouse sera diluted 100 times with the reaction buffer of
the kit were added to a microcup coated with a mixture of hu-
man nuclear antigens (three types of RNP epitope [70k, RNP-A,
and RNP-C], native Sm, native SS-A, recombinant SS-B, re-
combinant Scl-70, cenp-B, recombinant Jo-1, and 
 
 
 
 phage DNA
antigen) and incubated for 1 h at room temperature. The anti-
bodies bound to the plate were detected using goat anti–mouse
Ig’s conjugated to HRP (ICN Biomedicals) at a dilution of
1:1,000. The peroxidase activity was detected using TMB as a
substrate. The color reaction was read at 450 nm using a micro-
plate reader (Titertek Instruments).
Anti–double stranded (ds) DNA antibody was detected by us-
ing anti-dsDNA detection kit (MBL). Mouse sera diluted 100
times with the reaction buffer of the kit were added to a micro-
cup coated with human dsDNA and incubated 1 h at room tem-
perature. The antibodies bound to the microplate were detected
using goat anti–mouse Ig’s conjugated to HRP (ICN Biomedi-
cals) at a dilution of 1:1,000. The peroxidase activity was detected
as described in the previous paragraph. The color reaction was
read at 450 nm using a microplate reader (Titertek Instruments).
 
Immunohistochemistry
 
20–36-wk-old mouse kidneys were
fixed with 4% paraformaldehyde/4% sucrose in 0.1 M phosphate
buffer, pH 7.2, and embedded in paraffin. 4-
 
 
 
m-thick sections
were prepared and mounted on silanized slide glasses. For immu-
nohistochemistry, sections were incubated for 60 min at room
temperature in PBS containing 0.1% Triton X-100 and 10% nor-
mal goat serum and were stained for 60 min at room temperature
with Cy3-conjugated F(ab
 
 
 
)2 of goat anti-mouse IgG (Jackson
ImmunoResearch Laboratories) used at a dilution of 1:100. The
sections were washed three times with PBS containing 0.1% Tri-
ton X-100 and observed by fluorescence microscopy.
 
Results
 
Preparation of MFG-E8 Mutant Proteins.
 
MFG-E8 is
produced and secreted by macrophages and works as a
bridging molecule between apoptotic cells and macro-
phages to promote phagocytosis of apoptotic cells. This
bridging function depends on an RGD sequence located in
the second EGF domain, and the mutant MFG-E8, desig-
nated as D89E, carrying a point mutation in an RGD mo-
tif, inhibited the phagocytosis of apoptotic cells by thiogly-
collate-elicited peritoneal macrophages (18). To examine
the effects of the D89E mutant protein in vivo, we pro-
duced the mutant D89E protein in 293T cells, and then
purified it by affinity chromatography. The purified D89E
protein showed a single band of 67 kD in SDS-PAGE that
was recognized by an anti-FLAG antibody (Fig. 1). No
other proteins were detected in SDS-PAGE, indicating a
high purity of the protein. We also produced and purified
another mutant (E1E2PT) lacking the C1 and C2 domains,
showing a band of 30 kD in SDS-PAGE.
 
The D89E Mutant Protein Inhibits Phagocytosis of Apoptotic
Cells by Phagocytes.
 
We have shown that D89E inhibits
the phagocytosis of apoptotic cells by thioglycollate-elicited
mouse peritoneal macrophages (18), which produce a large
amount of MFG-E8. We have also confirmed that D89E
inhibits the phagocytosis of apoptotic cells, but not phago-
cytosis of microspheres by BAM3 cells, a macrophage line
that produces Del-1, which is homologous to MFG-E8
(22, 23; unpublished data). In these cases, D89E works as a
dominant negative form of MFG-E8, or competes with
Del-1. Here, we examined whether D89E inhibits the
phagocytosis of apoptotic cells by macrophages that pro-
duced neither MFG-E8 nor Del-1. BMDMs and peritoneal
resident macrophages were pretreated with D89E protein,
and then cocultured with apoptotic thymocytes for phago-
cytosis. As shown in Fig. 2, D89E inhibited phagocytosis
by both kinds of macrophages in a dose-dependent man-
ner. On the other hand, the E1E2PT protein, which can-
not bind to PS exposed on apoptotic cells because it lacks
the C1 and C2 domains, did not affect the phagocytosis of
apoptotic thymocytes. These results indicated that BMDMs
and peritoneal resident macrophages recognize PS on apop-
totic cells for phagocytosis, and that the D89E protein can
inhibit apoptotic cell engulfment by a wide variety of
phagocytes by masking the PS on dead cells. We have pre-
viously shown that a high concentration of wild-type re-
combinant MFG-E8-L does not promote phagocytosis of
Figure 1. Preparation of recombinant
MFG-E8. The expression plasmids of D89E
carrying the RGE sequence instead of
RGD in the second EGF-like domain of
mouse MFG-E8, or E1E2PT lacking the
C1C2 domains were introduced into hu-
man 293T cells. Recombinant proteins in
the supernatants were purified using anti-
FLAG M2 affinity gel. D89E (lanes 1 and 3)
or E1E2PT (lanes 2 and 4) were separated
by SDS-PAGE on a 10/20% polyacryl-
amide gradient gel and stained with CBB
(lanes 1 and 2), or transferred to a PVDF
membrane and detected with anti-FLAG
antibody (lanes 3 and 4). Positions of mo-
lecular mass standard proteins are indicated
in kilodaltons on the left. 
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apoptotic cells, but rather inhibits this phenomenon (18).
We also tested the effect of wild-type recombinant MFG-
E8-L on phagocytosis of apoptotic cells by BMDMs and
peritoneal resident macrophages, and found that 4.0 
 
 
 
g/ml
of wild-type MFG-E8 had the inhibitory effects to the
same extent as the D89E protein (unpublished data).
Phagocytosis of apoptotic cells has immunosuppressive ef-
fects on phagocytes. That is, macrophages phagocytosing ap-
optotic cells produce higher levels of the antiinflammatory
cytokines IL-10 and TGF-
 
  
 
(24, 25). We next examined
whether the D89E protein has inhibitory effects on the im-
munosuppressant associated with phagocytosis of apoptotic
cells. Thioglycollate-elicited peritoneal macrophages were
cocultured with thymocytes irradiated with UV for phago-
cytosis. Then, the cells were stimulated with LPS for 20 h
and IL-10, TGF-
 
 
 
, and TNF
 
 
 
 levels in the supernatant was
measured by ELISA. IL-10 production (Fig. 3) by LPS in the
macrophages engulfing apoptotic cells was 10-fold higher
than that in the cells not engulfing apoptotic cells. D89E
dose dependently inhibited the augmentation of IL-10 pro-
duction associated with apoptotic cell engulfment, whereas
E1E2PT did not have any effects. In contrast to IL-10, apop-
totic cell engulfment did not change either TGF-
 
 
 
 or TNF
production in the macrophages, and D89E had little effect
on these cytokine productions.
 
Intravenous Injection of D89E Induces Autoantibody Produc-
tion in Mice.
 
The impairment of apoptotic cell phagocy-
tosis, or the exposure of a large number of apoptotic cells
causes autoantibody production in mice (26–28). To exam-
ine the effects on autoantibody production of the recombi-
nant MFG-E8 protein in vivo, we intravenously adminis-
trated the recombinant protein into normal mice, and
autoantibodies in sera were measured with an ELISA assay.
described in the previous section, both wild-type MFG-E8
and D89E proteins have the inhibitory effects on apoptotic
cell phagocytosis at a high concentration. However, be-
cause the D89E protein was more effective than the wild-
type protein at a low concentration (unpublished data), we
used the D89E protein for in vivo study. All mice injected
with the D89E protein developed anti-CL antibody after
four injections (Fig. 4 A), whereas none of the mice in-
jected with the E1E2PT protein was anti-CL antibody pos-
itive. The titer of antibody against CL did not decreased by
D89E addition to the assay (unpublished data), indicating
that the antibodies to CL in the sera were not cross-reac-
tive to the D89E protein. Injection of the D89E protein
without FLAG tag also induced anti-CL antibody produc-
tion (unpublished data), indicating that this autoantibody
production was not due to immunization of FLAG peptide
fused to the D89E protein. Anti-CL antibodies often cross-
react with PS, which is another anionic phospholipid. As
shown in Fig. 4 B, the sera from mice injected with the
D89E protein contained anti-PS antibody, whereas the
E1E2PT protein did not induce anti-PS antibody produc-
tion. We also examined ANA, and anti-dsDNA antibody
in the sera. ANA was initially detected by indirect immu-
nofluorescence on Hep-2 cells. All mice injected with the
D89E protein were ANA positive, whereas none of the
mice injected with the E1E2PT protein developed ANA
(Fig. 4 C). Most ANA-positive sera showed either homo-
geneous or speckled patterns, or a combination of both.
Figure 2. The D89E inhibits phagocytosis of apoptotic cells by macro-
phages. (A) Mouse bone marrow–derived macrophages (BMDM) or (B)
resident peritoneal macrophages (Resident pMac) were pretreated for 30
min with indicated concentrations of D89E or E1E2PT and were cocul-
tured with dexamethasone-treated apoptotic thymocytes from CAD-defi-
cient mice. The cells were stained for Mac-1 and TUNEL, analyzed by
flow cytometry, and the percentage of TUNEL-positive cells in the Mac-
1–positive population was determined. The assay was performed in tripli-
cate, and mean values are shown with SD. These results are representative
of three independent experiments.
Figure 3. D89E inhibits the enhanced production of IL-10 in macro-
phages that engulf apoptotic cells. Thioglycollate-elicited mouse peritoneal
macrophages were cocultured with or without UV-irradiated thymocytes
for 2 h in the absence or presence of indicated concentrations of the D89E
or E1E2PT protein. After washing twice, the macrophages were treated
with or without 1  g/ml of LPS for 20 h. The concentrations of IL-10 (A),
TNF  (B), and TGF-  (C) were determined by ELISA. The assay was per-
formed in triplicate, and mean values are shown with SD. These results are
representative of three independent experiments. 
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We also measured ANA with a plate coated with several
kinds of nuclear proteins that are potential antigens against
autoantibodies. Injection of D89E (Fig. 4 D), but not
E1E2PT, into mice induced ANA production. On the
other hand, anti-dsDNA antibody was not detected in the
mice injected with the D89E protein (Fig. 4 E).
We next administered different amounts of D89E pro-
tein into mice. 0.125–2.0 
 
 
 
g/ml of D89E solution was
prepared in PBS/2.5% syngeneic mouse serum and was in-
jected into mice six times at a weekly interval. Injection of
the D89E protein induced anti-CL antibody and ANA in a
dose-dependent manner (Fig. 5).
 
Coinjection of Apoptotic Cells Augments Autoantibody Pro-
duction Induced by D89E.
 
Intravenous injection of a large
number of apoptotic thymocytes induced autoantibody
production, especially anti-CL antibody (28). We exam-
ined whether D89E-induced autoantibody production was
augmented by coinjection of apoptotic thymocytes. Injec-
tion of heterologous 
 
 
 
2-glycoprotein I (
 
 
 
2GPI), which
can bind to anionic phospholipid, induces antiphospholipid
autoantibodies (29, 30). To avoid the contact of apoptotic
thymocytes to 
 
 
 
2GPI in FCS, thymocytes from C57BL/6
mice were suspended in DMEM/1% syngeneic mouse se-
rum and irradiated with 40 J/m
 
2
 
 UV light to induce ap-
optosis. After incubation for 20 h, TUNEL staining and
Annexin V staining showed that 
 
 
 
90% of thymocytes
underwent apoptosis (unpublished data). The cells were in-
travenously injected with or without the D89E protein
into syngeneic mice. As shown in Fig. 6, the injection of
apoptotic thymocytes alone induced anti-CL antibody pro-
duction, although the titer of the antibody was far lower
compared with those in the mice injected with the D89E
protein. When the mice were coinjected with apoptotic
thymocytes and the D89E protein, they showed a higher
titer of anti-CL antibody and ANA than those in mice in-
jected with the D89E protein alone. However, coinjection
of E1E2PT and apoptotic thymocytes did not cause en-
hanced production of autoantibodies (unpublished data).
These results suggested that the D89E protein injection
Figure 4. Intravenous injection of D89E induces autoantibody pro-
duction in mice. Either D89E or E1E2PT (0.6  g) were diluted in 300  l
PBS containing 2.5% normal syngeneic mouse serum (concentration, 2.0
 g /ml), and injected into C57BL/6 mice weekly for the total of four (A
and B) or six (C–E) injections. Blood samples were obtained 1 wk after
the last injection, and serum levels of anti-CL (A), anti-PS (B), and anti-
dsDNA (E) were evaluated by ELISA as described in Materials and Meth-
ods. ANAs were detected by indirect immunofluorescence on Hep-2
cells (C) and ELISA (D). Serum levels of autoantibodies in MRL/Mpj-
lpr/lpr mice (16–40 wk old) are shown as a control. Horizontal bars rep-
resent the means. Statistical significance was determined by a one-tailed
Mann-Whitney test. P indicates a difference with a P   0.01.
Figure 5. Dose-dependent effects of D89E on the development of au-
toantibodies. The D89E protein was diluted in PBS containing 2.5% nor-
mal syngeneic mouse serum at a concentration of 0.125, 0.5, or 2.0  g/
ml, and 300  l of the solution was injected intravenously into C57BL/6
mice. Mice were given six injections at weekly intervals and bled a week
after the last immunization. Serum levels of anti-CL (A) and ANA (B)
were measured by ELISA. *P indicates a difference with a P   0.05.
Figure 6. Coinjection of apoptotic cells augments autoantibody pro-
duction induced by D89E. Thymocytes were prepared from C57BL/6
mice, cultured in RPMI 1640 containing 1% syngeneic mouse serum,
and irradiated with 40 J/m2 UV light. After incubation for 20 h to induce
apoptosis, the indicated number of cells was intravenously injected with
or without 0.6  g of D89E protein into syngeneic mice. Serum levels of
anti-CL (A) and ANA (B) were measured by ELISA after four or six
weekly injections, respectively. Horizontal bars represent the means. *P
indicates a difference with a P   0.05. 
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caused autoantibody production by the inhibition of phago-
cytosis of apoptotic cells in vivo.
 
Sustained Elevation of Autoantibodies in Mice Injected with
D89E Protein.
 
We followed the titer of autoantibodies in
mice injected with the D89E protein over a long period. The
titer of anti-CL antibody (Fig. 7) was rapidly increased after
four injections of D89E, and it was not decreased even after
injections were stopped. We confirmed that the titer of anti-
CL antibody and ANA was sustained at least until week 32,
suggesting that autoantibody production was continuously
stimulated by endogenous autoantigens in the mice once self-
tolerance was broken by the injection of D89E protein.
 
Immunoglobulin Deposition in the Glomeruli of the Mice In-
jected with D89E Protein.
 
Autoantibody production often
causes deposition of Ig complexes in the glomeruli of kid-
ney and glomerulonephritis. We performed immunohis-
tochemical staining of the kidney sections from the mice
injected with D89E. Fig. 8 shows that deposition of IgG
was detected in the glomeruli of kidneys from mice in-
jected with the D89E protein, whereas no deposition was
observed in the kidneys from mice injected with E1E2PT.
We followed Ig deposition in injected mice 28 wk after
the initial injection of the D89E protein, and all of the
mice showed deposition in glomeruli at this point. Mice
injected with the D89E protein and apoptotic thymocytes
also showed immunoglobulin deposition in the glomeruli,
whereas the deposition was barely detectable in mice in-
jected with apoptotic cells alone. We also stained the kid-
ney sections of injected mice with an anti–mouse C3 anti-
body. However, C3 could not be detected in any sections
from mice injected with the D89E protein or D89E and
apoptotic cells (unpublished data).
 
Discussion
 
Apoptotic cells are swiftly engulfed by professional
phagocytes, such as macrophages and dendritic cells. We have
previously shown that MFG-E8, produced by activated
macrophages, links between apoptotic cells and phagocytes
to promote the engulfment of dying cells, and that the mu-
tant protein D89E inhibits phagocytosis (18, 22). Here, we
showed that D89E induced autoantibody production when
intravenously injected into normal mice. For this effect,
D89E requires its binding domains to PS exposed on apop-
totic cells.
Many molecules have been proposed to be involved in
the phagocytosis of apoptotic cells (10, 12, 31). Some of
these molecules were demonstrated to be responsible for
engulfment of apoptotic cells in vivo. Mer-deficient mice
showed impaired phagocytosis of apoptotic immature T
cells in the thymus (26). The clearance of apoptotic cells
Figure 7. Sustained elevation of autoantibodies in mice injected with
D89E. Titers of autoantibodies were followed over 32 wk after immuni-
zation. C57BL/6 mice were injected intravenously with 300  l of 2.0
 g/ml D89E. Injections were administered weekly for a total of four im-
munizations (arrows). Mice were bled 2, 4, 9, 18, 25, 30, and 32 wk after
the first immunization. Anti-CL (A) and ANA (B) were measured by
ELISA as described in Materials and Methods.
Figure 8. Immunohistochemical detection of IgG deposition in the glo-
meruli of kidneys in mice injected with D89E. C57BL/6 mice were in-
jected intravenously with D89E or E1E2PT with or without apoptotic thy-
mocytes six times at weekly intervals. Kidneys obtained 17 wk after the
initial injection were fixed with 4% paraformaldehyde and embedded in
paraffin. The sections were stained with Cy3-conjugated F(ab )2 of goat
anti-mouse IgG and were observed with fluorescence microscopy. 25 wk-
old MRL/lpr mice (E) were used as a positive control. (A) 0.5  g/ml
D89E, (B) 2.0  g/ml E1E2PT, (C) 2.0   107 UV-irradiated thymocytes,
and (D) 2.0  g/ml D89E with 2.0   107 of UV-irradiated thymocytes. 
Asano et al.
 
465
injected into the mouse peritoneum was delayed in mice
with homozygous C1q deficiency, which is a component
of the complement classical pathway (32). Both Mer- and
C1q-deficient mice spontaneously showed autoantibody
production, and developed glomerulonephritis (27, 33).
Moreover, recently, we have established MFG-E8–defi-
cient mice, which showed impaired phagocytosis of apop-
totic B cells in the germinal center of the spleen and suf-
fered from autoimmune diseases with ANA and anti-DNA
antibodies production (34). Judging from these results, it is
most likely that the administration of D89E led to autoanti-
body production in mice by inhibiting phagocytosis of ap-
optotic cells in certain organs. The enhanced production of
autoantibodies by the coinjection of apoptotic cells with
D89E supports this model. A small amount of D89E (
 
 
 
1
 
 
 
g per mouse) injection was sufficient to induce autoanti-
bodies production, suggesting that disturbing the clearance
of even a small number of apoptotic cells can cause autoan-
tibodies production if occurring repeatedly.
In spite of increasing evidences that the impairment of
apoptotic cell clearance causes autoantibody production,
the underlying mechanisms remain elusive, and several
possibilities may arise. Liu et al. (35) reported that when
apoptotic cells loaded with an exogenous protein (e.g.,
ovalbumin) were injected into mice, immunotolerance for
the protein was induced in the animal. Injected apoptotic
cells were phagocytosed by CD8
 
 
 
 dendritic cells in the
spleen, which in turn presented cell-associated proteins to
induce tolerance. These findings suggest that peripheral
immune tolerance may be maintained by consistent presen-
tation of self antigens by dendritic cells and macrophages
that phagocytose dying self cells during physiological tissue
turn over, and that the inhibition of the phagocytosis may
cause the breakdown of self-tolerance. Phagocytosis of ap-
optotic cells has immunosuppressive effects on phagocytes,
and the D89E protein inhibits the enhanced production of
IL-10 in LPS-stimulated macrophages with apoptotic cells
(Fig. 3). Thus, it is possible that D89E induces inflamma-
tion in association with apoptotic cell death and subsequent
phagocytosis of cell corpses in vivo, and consequently,
leads to the breakdown of self-tolerance. Alternatively, the
clearance of dead cells prevents the release of potentially
toxic or immunogenic intracellular materials from dead cell
corpse. A recent paper by Shi et al. (36) described that uric
acid, released from injured cells, stimulates dendritic cell
maturation, and acts as an endogenous adjuvant. Heat shock
protein 70 can also modulate immune responses by pro-
moting functional maturation of dendritic cells (37). Im-
paired phagocytosis of apoptotic cells results in secondary
necrosis of dead cells, and the released materials from the
cell corpses may induce abnormal immune responses in-
cluding stimulation of self-reactive T cells. Nevertheless,
impairment of apoptotic cell phagocytosis can cause the
breakdown of self-tolerance, and further study to reveal the
precise mechanisms of this phenomenon should be re-
quired for a deeper understanding of autoimmune diseases.
MFG-E8 is expressed in a limited kind of macrophage.
In physiological conditions, only tingible body macro-
phages in the spleen and lymph nodes produced MFG-E8,
and the protein could not be detected in the mouse serum
at a 1 ng/ml order (unpublished data). We have previously
shown that there is an optimal concentration of MFG-E8
for promoting apoptotic cell phagocytosis, and that this ef-
fect changes toward inhibition above this concentration. In
fact, large amounts of wild-type recombinant MFG-E8 also
induced autoantibody production when injected into mice
(data not shown). These results strongly suggest that the
expression level of MFG-E8 is strictly regulated in the
macrophages in vivo, and that the excess amount of MFG-
E8 may cause production of autoantibodies in pathologi-
cal conditions. A large amount of MFG-E8 is produced
in thioglycollate-elicited peritoneal macrophages, whereas
resident peritoneal macrophages shows no expression, sug-
gesting that large amounts of MFG-E8 may be produced in
the macrophages in response to inflammation. In another
case, the induction of MFG-E8 gene expression was found
to occur in the mammary gland during lactation (38, 39). It
will be of considerable interest to examine the correlation
between MFG-E8 production and the levels of autoanti-
bodies in patients with autoimmune diseases.
MFG-E8 has two C domains that share homology with
the discoidin family, including the lipid-binding C domain
of blood coagulation factor V and factor VIII. These coagu-
lation factors bind to phospholipids including PS on platelets
via the C domain to proceed the coagulation cascade. Shi
and Gilbert (40) reported that purified MFG-E8 inhibited
blood coagulation by competing with coagulation factors for
membrane-binding sites, suggesting that MFG-E8 could
serve as an anticoagulant drug. However, the present paper
may caution against MFG-E8 usage as a therapeutic drug.
In summary, the D89E protein has inhibitory effects on
the phagocytosis of apoptotic cells by a wide variety of
phagocytes, and induces autoantibodies production when
injected into mice. These results imply a relationship be-
tween apoptotic cell phagocytosis and autoimmune disease.
Further studies of the mechanisms of phagocytosis of dead
cells will be required to reveal the pathophysiology of hu-
man autoimmune diseases.
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